Browsing by Yonsei Author : Cho, Byoung Chul

Name:
조병철 [Cho, Byoung Chul] http://orcid.org/0000-0002-5562-270X
Department :
College of Medicine - Dept. of Internal Medicine
Y-HRN :
(Yonsei Health Research Network)
Scopus ID :
(7401747804)

Keyword Cloud

Researcher Network

This table browses all dspace content
Issue DateTitleYonsei Author(s)Type
2020Patient-reported outcomes from FLAURA: Osimertinib versus erlotinib or gefitinib in patients with EGFR-mutated advanced non-small-cell lung cancer 조병철Article
2020Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC조병철Article
2019Promising preclinical platform for evaluation of immuno-oncology drugs using Hu-PBL-NSG lung cancer models조병철, 표경호Article
2019Patient-reported outcomes with durvalumab after chemoradiotherapy in stage III, unresectable non-small-cell lung cancer (PACIFIC): a randomised, controlled, phase 3 study조병철Article
2019Impact of Treatment-Related Lymphopenia on Immunotherapy for Advanced Non-Small Cell Lung Cancer김시내, 김혜련, 박주영, 변화경, 윤홍인, 이창걸, 조병철, 조연아, 조재호, 홍민희Article
2019Dynamic changes in PD-L1 expression and CD8+ T cell infiltration in non-small cell lung cancer following chemoradiation therapy김혜련, 박성용, 심효섭, 이창영, 정인경, 조병철, 차윤진, 최은아, 홍민희Article
2019Hyperprogressive disease during PD-1/PD-L1 blockade in patients with non-small-cell lung cancer김혜련, 박성용, 심효섭, 안병철, 윤홍인, 이진구, 이창영, 조병철, 표경호, 홍민희Article
2019Predictive factors for the development of diabetes in cancer patients treated with phosphatidylinositol 3-kinase inhibitors강은석, 김규리, 김혜련, 이병완, 이용호, 조병철, 차봉수, 홍민희Article
2019Investigating Trk Protein Expression between Oropharyngeal and Non-oropharyngeal Squamous Cell Carcinoma: Clinical Implications and Possible Roles of Human Papillomavirus Infection 윤선옥, 조병철, 조윤아Article
2019A phase Ib study of the combination of afatinib and ruxolitinib in EGFR mutant NSCLC with progression on EGFR-TKIs김혜련, 조병철, 홍민희Article
2019Comprehensive analysis of the characteristics and treatment outcomes of patients with non-small cell lung cancer treated with anti-PD-1 therapy in real-world practice 김혜련, 박성용, 심효섭, 안병철, 윤홍인, 이창영, 조병철, 표경호, 홍민희Article
2019YH25448, an Irreversible EGFR-TKI with Potent Intracranial Activity in EGFR Mutant Non-Small Cell Lung Cancer김혜련, 조병철, 표경호, 홍민희Article
2019Indoor radon exposure increases tumor mutation burden in never-smoker patients with lung adenocarcinoma김혜련, 박성용, 심효섭, 이창영, 조병철, 홍민희Article
2019Real-World Analysis of the Efficacy of Rebiopsy and EGFR Mutation Test of Tissue and Plasma Samples in Drug-Resistant Non-Small Cell Lung Cancer 김지형, 김혜련, 안병철, 조병철, 허수진, 홍민희Article
2019Molecular Diagnostic Assays and Clinicopathologic Implications of MET Exon 14 Skipping Mutation in Non-small-cell Lung Cancer김경아, 김상우, 심효섭, 이창영, 조병철Article
2019Neoadjuvant therapy for thymic neoplasms reduces tumor volume per 3D-reconstructed images but does not improve the complete resection rate김대준, 김혜련, 박성용, 백효채, 서지원, 송승환, 이진구, 이창영, 정경영, 조병철, 홍민희Article
2019Patient-Derived Cells to Guide Targeted Therapy for Advanced Lung Adenocarcinoma 김혜련, 안병철, 윤미란, 조병철, 표경호, 홍민희Article
2019Osimertinib versus Standard of Care EGFR TKI as First-Line Treatment in Patients with EGFRm Advanced NSCLC: FLAURA Asian Subset조병철Article
2019The Ratio of Peripheral Regulatory T Cells to Lox-1+ Polymorphonuclear Myeloid-derived Suppressor Cells Predicts the Early Response to Anti-PD-1 Therapy in Patients with Non-Small Cell Lung Cancer김혜련, 윤홍인, 정인경, 조병철Article
2019Investigating the Feasibility of Targeted Next-Generation Sequencing to Guide the Treatment of Head and Neck Squamous Cell Carcinoma 김상우, 김혜련, 조병철Article
2019Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial조병철Article
2019Dual-targeting of EGFR and Neuropilin-1 attenuates resistance to EGFR-targeted antibody therapy in KRAS-mutant non-small cell lung cancer조병철Article
2019Tumor microenvironment dictates regulatory T cell phenotype: Upregulated immune checkpoints reinforce suppressive function 김가민, 김혜련, 라선영, 박성용, 심효섭, 윤홍인, 이진구, 정경영, 조남훈, 조병철Article
2019High CD3 and ICOS and low TIM-3 expression predict favourable survival in resected oesophageal squamous cell carcinoma 김대준, 김혜련, 박성용, 신성관, 신수진, 조병철, 홍민희Article
2019Twist and Snail/Slug Expression in Oropharyngeal Squamous Cell Carcinoma in Correlation With Lymph Node Metastasis조병철Article
2019Characterization of head and neck squamous cell carcinoma arising in young patients: Particular focus on molecular alteration and tumor immunity김은경, 윤선옥, 조병철Article
2019NOVA1 induction by inflammation and NOVA1 suppression by epigenetic regulation in head and neck squamous cell carcinoma 고윤우, 윤선옥, 조병철Article
2019Updated Efficacy and Safety Data and Impact of the EML4-ALK Fusion Variant on the Efficacy of Alectinib in Untreated ALK-Positive Advanced Non-Small Cell Lung Cancer in the Global Phase III ALEX Study 조병철Article
2019Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial조병철Article
2018Mechanisms of acquired resistance to first- and second-generation EGFR tyrosine kinase inhibitors조병철Article
2018Impact of Tumor Purity on Immune Gene Expression and Clustering Analyses across Multiple Cancer Types 조병철Article
2018Characteristics and Outcome of ROS1-Positive Non-Small Cell Lung Cancer Patients in Routine Clinical Practice김혜련, 안병철, 조병철, 홍민희Article
2018Enhancer Remodeling and MicroRNA Alterations Are Associated with Acquired Resistance to ALK Inhibitors.김혜련, 심효섭, 조병철, 표경호, 홍민희Article
2018Phase Ib/II study of the pan-cyclin-dependent kinase inhibitor roniciclib in combination with chemotherapy in patients with extensive-disease small-cell lung cancer. 조병철Article
2018Establishment of a platform of non-small-cell lung cancer patient-derived xenografts with clinical and genomic annotation김대준, 김진아, 김혜련, 박성용, 백순명, 심효섭, 윤미란, 이진구, 이한나, 조병철, 표경호, 홍민희Article
2018ERK-dependent IL-6 autocrine signaling mediates adaptive resistance to pan-PI3K inhibitor BKM120 in head and neck squamous cell carcinoma강한나, 김혜련, 윤미란, 조병철, 홍민희Article
2018Efficacy and safety of vinorelbine plus cisplatin chemotherapy for patients with recurrent and/or metastatic salivary gland cancer of the head and neck고윤우, 김진아, 김혜련, 윤선옥, 조병철, 최은창, 홍민희Article
2018Immune checkpoint inhibitors in epidermal growth factor receptor mutant non-small cell lung cancer: Current controversies and future directions조병철Article
2018Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study조병철Article
2018Profiling of protein–protein interactions via single-molecule techniques predicts the dependence of cancers on growth-factor receptors조병철Article
2018Acquired resistance to EGFR targeted therapy in non-small cell lung cancer: Mechanisms and therapeutic strategies조병철Article
2018Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer조병철Article
2018A Clinical Trial of Combination Neoadjuvant Chemotherapy and Transoral Robotic Surgery in Patients with T3 and T4 Laryngo-Hypopharyngeal Cancer금기창, 김다희, 김세헌, 김혜련, 조남훈, 조병철Article
2017ASCEND-8: A Randomized Phase 1 Study of Ceritinib, 450 mg or 600 mg, Taken with a Low-Fat Meal versus 750 mg in Fasted State in Patients with Anaplastic Lymphoma Kinase (ALK)-Rearranged Metastatic Non-Small Cell Lung Cancer (NSCLC)조병철Article
2017Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer조병철Article
2017Phase 2 study of intermittent pulse dacomitinib in patients with advanced non-small cell lung cancers조병철Article
2017Dose-Response Relationship between Radiation Dose and Loco-regional Control in Patients with Stage II-III Esophageal Cancer Treated with Definitive Chemoradiotherapy 김현주, 신성관, 이상길, 이용찬, 이창걸, 조병철Article
2017Architectural patterns of p16 immunohistochemical expression associated with cancer immunity and prognosis of head and neck squamous cell carcinoma김은경, 김혜련, 윤선옥, 조병철, 허수진Article
2017Activity and safety of AZD3759 in EGFR-mutant non-small-cell lung cancer with CNS metastases (BLOOM): a phase 1, open-label, dose-escalation and dose-expansion study김혜련, 조병철Article
2017Rare Incidence of ROS1 Rearrangement in Cholangiocarcinoma 박영년, 유정은, 임선민, 조병철Article

Browse